Lyra Therapeutics(LYRA)
$0.190.00 (0.00%)
LYRA
Lyra Therapeutics stock drug pipeline
$0.19
At close:0.00 (0.00%)
Want to see LYRA full AI Analyst Report?
Lyra Therapeutics (LYRA) Drug Pipeline
360 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Background Therapy, Lyr-210, Sham Procedure Control | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase III | Completed | Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2) | Mar 08, 2022 | ― |
| Background Therapy, Lyr-210, Sham Procedure Control | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase III | Completed | Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults | Jan 21, 2022 | ― |
| Lyr-220 Design 1 (Part 1 Only), Lyr-220 Design 2 (Part 1 And Part 2), Bilateral Sham Procedure Control (Part 2) | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Phase II | Completed | LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) | Aug 27, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Background Therapy, Lyr-210, Sham Procedure Control | Phase III | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Completed | Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2) | Mar 08, 2022 | ― |
| Background Therapy, Lyr-210, Sham Procedure Control | Phase III | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Completed | Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults | Jan 21, 2022 | ― |
| Lyr-220 Design 1 (Part 1 Only), Lyr-220 Design 2 (Part 1 And Part 2), Bilateral Sham Procedure Control (Part 2) | Phase II | Chronic Sinusitis, Chronic Rhinosinusitis (Diagnosis) | Completed | LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study) | Aug 27, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lyra Therapeutics, Inc. (LYRA) have in its pipeline
Lyra Therapeutics LYRA is currently developing the following drugs: Background Therapy, Lyr-210, Sham Procedure Control, Lyr-220 Design 1 (Part 1 Only), Lyr-220 Design 2 (Part 1 And Part 2), Bilateral Sham Procedure Control (Part 2). These drug candidates are in various stages of clinical development as the company works toward FDA approval.
